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采用回顾性研究，收集 2004 年-2011 年中山医院妇产科上皮性卵巢癌患者的
病理标本，利用免疫组化技术检测 Dyrk1b 在 30 例上皮性卵巢癌、20 例上皮性

















采用 RT-PCR、Western-Blotting、免疫荧光等分子生物学技术从 RNA 及蛋白
水平分别检测 Dyrk1b 在各种卵巢癌细胞株中的表达，并采用 siRNA 技术沉默
















瞬时沉默 Dyrk1b 的表达的研究证实 Dyrk1b 可能通过 Caspase-3、PARP 等参与
细胞的凋亡过程，有望成为卵巢癌治疗的新的靶基因。 

















Introduction and objectives 
Ovarian cancer is a common gynecological malignant tumors, and of which 60% 
-90% are epithelial ovarian tumor.Becase of the lack of effective early diagnosis and 
treatment methods, a majority of patients had distant metastases at the time of 
diagnosis. In clinical we use tumor markers, such as of CA125, CA199, AFP,et 
al,combined with the imageological diagnosis as diagnostic method.And after surger 
the five-year-survival be only 20%-30%.The morbidity of ovarian neoplasms is in the 
rank of the third in female genital malignant tumor,but the first mortality.Therefore 
finding a new target gene is desperately needed. 
Minibrain-related kinase (Mirk)/dual-specificity tyrosine-regulated kinase 
(Dyrk)1B is one of the best functionally characterized members of the 
Dyrk/Minibrain family of dual-specificity kinases.Studies have  revealed that Mirk is 
a multifunctional Ser/Thr kinase that plays a critical role in muscle differentiation by 
regulatory effects on motility, transcription, cell cycle progression, and cell survival. 
Mirk is expressed in several solid tumors, including colon carcinoma, prostate 
carcinoma, pancreatic ductal adenocarcinoma, rhabdomyosarcoma, and nonsmallcell 
lung carcinoma, where it may play a role in the occurrence and development of the 
tumor cells. 
RNA interference(RNAi) is a kind of specific gene silence post transcription,it 
can lead to the sequence-specific degradation of endogenous RNAs that match the 
double-stranded RNA(dsRNA) by introducing the dsRNA into cells.In this 
experiment,we block the Dyrk1b gene with RNAi and discuss the change of ovarian 
carcinoma cells on proliferation and apoptosis.It includes two parts in this report.The 
first part ,title:Expression and clinical significance of Mirk/Dyrk1b in ovarian 
carcinoma. Objective: To determine the expression of Mirk/Dryk1b（Minibrain-related 















ovarian cancers and  its correlation with clinical features. The second part ,title: The 
expression and effection in cell survival of Dyrk1b/Mirk in ovarian cancer cells. 
Objective: To determine the expression of Dyrk1b/Mirk in ovarian cancer cells and 
the effect in cell survival. 
Methods 
The first part: Immunohistochemical staining method was used to detect the 
expression of Mirk/Dyrk1b in 30 samples with epithelial ovarian carcinoma, 20 
samples of benign epithelial ovarian cystadenoma, 10 cases of normal ovarian tissues. 
The second part: Using RT-PCR, Western-Blotting, immunofluorescence and 
other molecular biology techniques to detect the expression of Dyrk1b, and 
knockdown Dyrk1b by small interfering RNAs(siRNAs) using transient transfection 
technique, to detect apoptosis related protein  Caspase-3、PARP, and the apoptosis 
rate. 
Results 
The first part:Dyrk1b in epithelial ovarian carcinoma was significantly higher 
than that in benign epithelial ovarian cystadenoma and normal ovarian tissue (P＜
0.05). There are some certain correlations between the positive rates of Dyrk1b and 
histological grade  (P＜0.01), but was not associated with clinical stage and lymph 
node metastasis(P＞0.05). 
The second part: Dyrk1b is overexpressed in ovarian cancer cells. Dyrk1b 
knockdown by small interfering RNA induced cell apoptosis concomitant with 
upregulation of caspase-3 and PARP. 
Conclusion 
The first part: Dyrk1b in epithelial ovarian carcinoma is highly expressed which 
may be involved in the carcinogenesis and cancer development, and can be expected 
to be a therapeutic target in ovarian carcinoma. 
The second part:These results suggest that Dyrk1b is overexpressed and mediates 
cell survival in ovarian cancer cells, and may be a novel therapeutic target. 
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英语缩写 英文全称 中文全称 
aa Aminoacid 氨基酸 
AMP Ampicillin 氨苄青霉素 
Bp Base pair  碱基对 
BSA Bovine serum albumin 牛血清白蛋白 
cDNA Complementary deoxynucleic acid 互补脱氧核苷酸 
DNA Deoxynucleic acid 脱氧核苷酸 
DMEM Dulbecco’s minimum essential medium 基本培养基 
DEPC Diethyl phrocarbonate 焦炭酸二乙酯 
DMSO Dimethyl sulfoxide 二甲基亚砜 
dNTP Depxynucleosine triphosphate 脱氧核苷三磷酸 
EDTA Ethylene daminetetraacetic acid 乙二胺四乙酸二钠 
FACs Fluoresce；nce activated cell sorter  流式细胞仪 
Kb Kilobase 千碱基 
HRP Horse radish peroxidase 辣根过氧化物酶 
Ig Immunoglobulin 免疫球蛋白 
KDa Kilodalton 千道尔顿 
OD Optical density 光密度 
Oligo Oligonucleotide 寡核苷酸 
PAGE Polyacrylamide gel electrophoresis 聚丙烯酰胺凝胶电泳 
PEG Polyethylene glycol 聚乙二醇 
PBS Phosphate-buffered saline 磷酸缓冲液 
PCR Polymerase chain reaction 聚合酶链式反应 
PI Propidium iodide 碘化丙锭 















RNAi RNA interference RNA 干扰 
Rnase Ribonuclease 核糖核酸酶 
Rpm Rounds per minute 每分钟转数 
英语缩写 英文全称 中文全称 
RT-PCR Reverse-transcripted polymerase 
chainreaction 
逆转录-聚合酶链式反应 
SDS Sodium hairpin sulfate 十二烷基磺酸钠 
SiRNA Small hairpin RNA 小分子干扰 RNA 
TAE Tris-acetate-EDTA buffer TAE 缓冲液 
TBS Tris-buffered saline TBS 缓冲液 
TMEMD N,N,N’,N’-terametuhlethylenediamine N,N,N’,N’-四甲基乙二
胺 
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1.微量移液器 （0.1~500μ l）                    德国Eppendorf 公司 
2.冰箱                                               青岛海尔公司 
3.可控式电热鼓风恒温干燥箱                               精宏公司 
4.微波炉                                                 上凌公司 
5.石蜡包埋机                                  Shandon Histoantre3 
6.石蜡切片机                                             莱卡2135 
7.摊片机                                             湖北孝感公司 
8.烤箱                                                   恒宇公司 
9.光学显微镜                                         OLYMPUS 公司 
10.全自动显微照相系统                                OLYMPUS 公司 
3、实验试剂 
1.DYRK1B Antibody(C-term) Purified Rabbit Polyclonal Antibody(Pab) 
ABGENT公司 
2.Monoclonal Mouse Anti-Human Ki-67 Antigen             Dako 公司 
3.Purified Mouse Anti-ALDH                                  BD公司 
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5.抗体稀释液(ZLI-9029)                   北京中杉金桥生物有限公司 
6.柠檬酸盐抗原修复液（pH 6.0，100³）（MVS-0100）     福州迈新公司 
7.多聚赖氨酸Poly-L-Lysine（10³）（GLU-0041）         福州迈新公司 
8.DAB 显色试剂盒(DAB-0031)                           福州迈新公司 
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